Screener Summaries Updates Institutions Sign In More Updates › Other Events › ALLR Other Events · Jun 22, 2026
Allarity Therapeutics announced the presentation of a Trial-in-Progress poster at the ESMO Gynaecological Cancers… ALLR Allarity Therapeutics, Inc.
Allarity Therapeutics announced the presentation of a Trial-in-Progress poster at the ESMO Gynaecological Cancers Congress 2026, held June 17–19, 2026, in Copenhagen, Denmark. The company operates in the biotechnology industry and develops therapeutic treatments for cancer.
More from Allarity Therapeutics, Inc. Allarity settles $4.9M Novartis liability for $1M and signs first CLIA lab services contract Nov 2, 2026 Allarity terminates $6M equity purchase agreement with Tumim Stone to pursue alternative financing Oct 30, 2026 Allarity Therapeutics announced that its wholly-owned subsidiary, Allarity Sponsor LLC, formed a new special purpose… Sep 14, 2026 Allarity Therapeutics reported financial results for the second quarter ended June 30, 2026, ending with $26.9 million… Aug 14, 2026 Allarity Therapeutics, Inc. held its annual meeting on June 26, 2026, where stockholders approved the election of… Jul 1, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
